It is accepted that Black subjects differ from White and Indian hypertensives in their response to hypotensive agents. Black hypertensives in the USA have a lower urinary tissue kallikrein (TK) excretion levels compared to White hypertensives. It has been suggested that Black patients respond better to thiazide diuretics compared to ␤-blockers because thiazides increase whereas ␤-blockers decrease tissue kallikrein excretion. This study compares the excretion of urinary TK in Black and Indian hypertensive and normotensive subjects. Urinary TK levels were measured with the selective, synthetic
Introduction
The kallikreins are serine proteases (enzymes) that are found in different tissues, cells and biological fluids. In humans, they comprise two main groups: plasma and tissue kallikreins (TKs). Both the kallikreins are synthesised as precursor enzymes. 1 Expression of the TK family in humans is controlled by three genes, of which KLK1 is expressed in the kidney and KLK3 (prostate-specific antigen) and KLK2 in the prostate. 2 TK occurs in cells of many tissues, such as the kidney, lung, anterior pituitary, brain and the gastric mucosa. 1, 3, 4 The synthesis of plasma kallikrein in hepatocytes is regulated by a single gene, and the enzyme is secreted into the circulation as an inactive molecule where it forms heterodimer complex bound to H-kininogen. 5 The two types of kallikrein differ in their biochemical properties (molecular weight, substrate specificity, immunological characteristics), but only resemble one another in their capacity to release kinin from the endogenous protein substrates known as H-and L-kininogens. 6, 7 Circulating Hkininogen, the substrate for the kallikreins, is synthesised like plasma kallikrein by hepatocytes, and secreted into the circulation; additionally, L-kininogen is synthesised in tissues. The whole of the kallikrein-kininogen complex is bound to the outer peptic substrate with the sequence of H-D-Val-Leu-ArgpNA. Ten hypertensive patients on placebo therapy and 10 normotensive Black and Indian subjects provided three samples at weeks 0, 2 and 4 for the determination of urinary TK. The results were analysed using analysis of variance to compare the two racial groups. There were no significant differences in urinary TK values of the three bi-weekly individual samples. Urinary tissue kallikrein values (ng TK/g protein) in Indian hypertensives were in general lower than Black hypertensives. membrane surface of the human neutrophil. 8 Contact between activate kallikrein and the kininogens, either in the interstitial tissue space or capillary circulation, leads to the formation of kinins. Kinins are vasoactive nona-or deca-peptides that relax arterioles, constrict veins, increase capillary permeability, and interact with sensory nerve terminals to evoke pain. Therefore, these bioactive peptides are attractive autocoids that regulate secondary mediators and cell function.
The various cellular actions of kinins are modulated by the activation of one of the two or both receptors, B 2 and B 1 .
9,10 Both the kinin receptors have been cloned, and are linked to specified G protein-coupled second messenger signalling systems. 11, 12 The B 2 receptor is constitutive, whereas the B 1 receptor is believed to be induced in sepsis and cellular inflammation. Upregulation of the B 1 receptor is influenced by cytokines and growth factors. An important discovery has been the cellular localisation of kinin B 1 receptors in human tissues. 13 The humoral regulation of blood pressure is primarily controlled by the two opposing systems, the renin-angiotensin and the TK-kinin. Renal TK is sited in specific cells of the connecting tubule cells of the distal nephron.
14 Intracellularly, the kallikrein enzyme is stored in luminal granules, but also distributed along the basal infoldings of the cell. Therefore, there exists the possibility of both paracrine and exocrine release of the enzyme in response to appropriate stimuli. Evidence suggests that the secretion of TK into the urine or the interstitial tissue space may be regulated by afferent arteriolar pressure and the concentration of potassium within the distal nephron, 15 as well as the presence of the serpin inhibitor, kallistatin. 16 Renal kininogen is formed in the connecting tubule cells (in cells different from those that synthesise kallikrein) and the collecting ducts. When kallikrein comes into contact with kininogen, either in the interstitial tissue space/capillary circulation or in the lumen of the distal nephron and collecting ducts, kinins are formed. 1 The earliest reports that urinary excretion of TK was significantly reduced in hypertensives, relative to normotensive individuals, was published in 1934 by Elliot and Nuzum. 17 However, it took 37 years before supporting evidence for this observation began to appear in the literature. 1 It is recognised that Black hypertensive patients respond well to thiazide diuretics, vasodilators like hydralazine or prazosin, a combined ␣-␤-blocker like labetalol or carvedilol and calcium channel blockers. It is accepted that in Black hypertensive patients a thiazide diuretic should be routinely used alongside a ␤-blocker or an angiotensin-converting enzyme (ACE) inhibitor. 18 Warren and O'Connor 19 proposed that racial (Black-White) differences in clinical severity, haemodynamic profile and response to therapy of essential hypertension may be mediated largely by the renal kallikrein-kinin system. They felt that deficiency of the kallikrein-kinin renal vasodilatory system may explain many of the unique features of essential hypertension in at least some Black people, especially older subjects with low plasma renin activity. Antihypertensive agents, like propranolol, which decrease TK excretion, may not be effective in all Black subjects. Conversely, if a drug like a thiazide diuretic increases urinary TK excretion in Black people, it may have a special advantage in this group of patients. Tailoring of antihypertensive therapy on the basis of urinary TK response may therefore have clinical implications. 19 Patients with low TK levels may respond better to calcium channel blockers than those with normal TK levels. Blood pressure was significantly lower in patients with normal TK who were treated with ACE inhibitors. It has been suggested that the urinary kallikrein-kinin system might play some contributory role in moderating the hypotensive action of ACE inhibitors. 20 Doxazosin, a vasodilator, stimulates urinary TK. 21 Oral TK decreases blood pressure only in salt-sensitive patients. 22 In both the salt-sensitive and saltresistant patients a marked increase in the 24-h urinary excretion of sodium was observed after oral glandular kallikrein treatment (derived from porcine pancreas). 22 Unlike Black patients, Indian hypertensive patients respond to antihypertensive agents similarly to White hypertensives. The question therefore arises as to whether the urinary excretion pattern of TK differs in hypertensive as well as in normotensive Black and Indian patients. The study was therefore designed to measure excretion values for urinary TK in four groups: Black normotensive, Black hypertensive, Indian normotensive and Indian hypertensive.
Patients and methods

Aimed data
Twenty hypertensive patients, mild to moderate (10 Black: eight women and two men; 10 Indian: eight women and two men), and 20 normotensive subjects (10 black: eight women and two men; 10 Indian: eight women and two men) entered the study. The mean age of the Indian hypertensive patients was 52.3 (s.d. 7.27) and the mean age of the Indian normotensive subjects was 48 (s.
Design
The study took place over 4 weeks. In week 0 hypotensive therapy was stopped in 20 hypertensive patients on treatment. They were placed on placebo to control for the effect of antihypertensive drugs on the excretion of urinary TK. The patients who were on placebo during the washout period of clinical trials of antihypertensive drugs were not specifically on placebo for the present study. Informed consent was obtained from the patients. Ethical approval of the trial was obtained from the Ethics Committee of the University of Natal. Three morning samples of urinary TK values were measured at weeks 0, 2 and 4.
Micro-assay for TK
The enzyme activity of TK was measured on a selective peptide-nitroanilide substrate H-D-Val-Leu-Argparanitroaniline. 23 The method used for measurement of TK was that developed by Rahman et al in 1994. 24 To determine TK activity, 50 l of human urinary kallikrein standard (Protogen) were added to 100 l of assay buffer (0.2 M Tris/HCl, pH 8.2), containing soya bean trypsin inhibitor (SBTI) (300 g; SBTI inhibits trypsin-like proteases but not TK) and EDTA (375 g); a final volume of 150 l was achieved by adding buffer where necessary. The microtitre plate was incubated at 37°C for 30 min, and then 50 l selective synthetic substrate (H-DVal-Leu-Arg-pNA dissolved in specially deionised distilled water to a concentration of 1.5 mM and stored at 4°C) were added to all samples. After further incubation for 3 h (optimum incubation time determined in time-course experiments) at 37°C, the changes in optical density were recorded at 405 nm in a ELISA plate reader (Bio-Rad Microplate Reader, Model 3550).
For each experiment, a TK standard curve was generated in duplicate with concentrations ranging from 12.5 to 400 ng/ml in amidase assay buffer (0.2 M Tris-HCl, pH 8.2). Blanks contained only: (i) the assay buffer (150 l) and substrate (50 l); (ii) the assay buffer (100 l), SBTI (50 l) and substrate (50 l); (iii) the assay buffer (100 l), SBTI (50 l) and sample (50 l). Non-specific absorbance (blanks) was deducted from each standard or sample value. Values in test samples were calculated by reference to the TK standard curve and expressed as ng TK/ml, and then expressed as specific activity in ng TK/g protein, and also as a function of urinary creatinine [ngTK/g protein/mol Cr (Creatinine)].
Urinary electrolytes
Urinary sodium and potassium were measured by flame photometry. Normal sodium and potassium ranges in spot urine samples are believed to be 40-120 mol/ml for sodium and 25-125 mol/ml, respectively.
Statistical analysis
Analysis of variance was used to compare the four study groups at weeks 0, 2 and 4, and repeated t-test were used for pairwise comparisons (ie, to compare Indian normotensives to hypertensives, Black normotensives to hypertensives, Black hypertensives to Indian hypertensives, and Black normotensives to Indian normotensives). Non-parametric tests (Kruskal-Wallis and Wilcoxon two-sample tests) confirmed the results. Descriptive statistics are presented as means and standard deviations. Distributions generally did not deviate significantly from normal. In view of the sample size the medians and ranges were also determined.
Results
Validity of spot urine collections
When the protocol of 1-h spot urine collection for the present study was designed, the question of 24-h urine collection was considered, but proved to be impracticable because of the ambulant status of the patients. In 1991 Tsai et al 25 indicated that a shorter period of urine collection correlated well with data for protein, urinary creatinine and urinary TK excretion from 24-h urine collections. Since the aim of this study was to compare changes within specific time frames, it was assumed that the measurement of the various parameters for each group could be meaningfully compared by means of non-parametric statistical analysis.
Excretion of urinary TK
The aims of the study were: (i) to determine the TK excretion profiles of normotensive Indians and Black subjects; and (ii) to compare any differences in the excretion pattern of each of these groups. At week 0, antihypertensive therapy was discontinued and patients given a placebo for the next 4 weeks. Although data were variable, the distributions of TK concentrations were, in general, fairly symmetrical, and a test for normality did not show significant deviations. Although, TK excretion is usually expressed as a specific activity (ng TK/g protein), it is also meaningful to present values as a function of urinary creatinine (ng TK/g protein/mol Cr).
Our results confirm that the renal excretion of TK was reduced in Black hypertensives. However, we report the new findings of a similar trend in Indians. Furthermore, no previous study has reported a timedependent comparison of the excretion of TK with respect to hypertension and ethnicity. The specific activity of TK (ng/g protein) was in general higher in the Black hypertensives than the Indian hypertensives, whereas the normotensives in the two groups showed variable trends that were not significantly different. The results therefore appear to suggest ethnic differences in the excretion pattern of TK by hypertensive Black patients and Indians, even though the excretion pattern of TK varied somewhat between the subgroups.
Urinary electrolytes
Urinary electrolytes were determined since it has been postulated that urinary sodium and potassium may show a correlation with the renal excretion of TK. The urinary excretion of sodium over time was not significantly different between the normal and in hypertensive patients in each of the two ethnic groups. There was also no significant difference between the normotensive Black and Indian subjects. No statistical differences were observed either between the ethnic groups or the blood pressure subsets of patients with regard to the urinary excretion of potassium.
Blood pressure
There were differences between hypertensives and controls. There were no significant differences between Black and Indian subjects.
Discussion
The humoral regulation of renal blood flow comprises vasoconstrictor/antidiuretic systems balanced by vasodilator/diuretic systems. Of these renal kinins, produced by TK through the hydrolysis of kininogen, increase renal blood flow and enhance excretion of sodium and water. Reduced secretion TK into the lumen of the nephron is believed to indicate a fall in the paracrine release of the enzyme into the interstitial tissue space, and the consequent lowered formation of kinins would result in increased renal vascular tone and a reduced capacity to excrete a sodium load.
Evidence suggests that the excretion of renal TK varies directly with potassium intake. The effect of potassium on the secretion of TK was first demonstrated in experiments with renal cortical slices in vitro and in the isolated perfused kidney. 15 An increase in the excretion of TK induced by a high intake of potassium was higher in hypertensives than in normotensive subjects, with the increase in White greater than in Black patients. 19 A high potassium diet produced hyperplasia and hypertrophy in the collecting tubule cells and the presence of a large number of secretory-like granules containing TK. 26 The role of potassium in the regulation of TK synthesis, storage and release in humans therefore needs to be critically studied.
Decreased excretion of urinary TK could also be due to the presence of inhibitors. Apart from alpha-1-trypsin, a renal TK inhibitor (kallistatin) has been isolated and purified, and its cDNA sequence has been determined. Kallistatin inhibits the enzymic activity. Kallistatin has been immunolocalised in tubules distal to the secretion of TK. The precise functional regulation of this inhibitor is not known, but could be important in the humoral regulation of TK and therefore blood pressure.
In human essential hypertension urinary TK excretion is reduced, and the question arises as to whether the expression of TK is inhibited in the offspring of hypertensive patients, as well as in Black patients, all of whom have a susceptibility to raised blood pressure. Furthermore, 50% of the general population in the USA are heterozygous for the renal TK gene. 27 They are dependent upon their dietary potassium for the urinary TK excretion levels (gene-environment interaction. 27 Urinary TK has been suggested as a marker for response to hypotensive agents in Black patients. 19 This study showed that the urinary TK levels were in general lower in Indian hypertensives compared to the Black hypertensive patients. The varying response in our Black patients may be elucidated further by inclusion of a wider heterogenous group and a larger set of patients. Discrepancies between the various studies could be accounted for by the heterogeneity of the population analysed, the degree of hypertensive nephropathy and methods of measurement. 28 None of the patients in our study had hypertensive nephropathy. It is possible the American Black subjects have an abnormal gene which is affected by a low potassium intake. 27 This abnormal renal TK gene may not be present in our Black population.
